4 - NRF2

Bo Zhu1,2,3, Lihua Zhu2, Zongxia Ge2

  • 1Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University; Institute of Neuroscience and Jiangsu Key Laboratory of Neuropsychiatric Diseases, Soochow University, Suzhou, Jiangsu Province, 215000, People's Republic of China.

概括

4-octyl itaconate (4OI) 通过激活KEAP1/NRF2通路来抑制树突细胞 (DC) 的成熟和功能. 这一发现对于开发基于DC的新型瘤免疫治疗策略至关重要.